Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
Hidemi Nakagawa, Osamu Nemoto, Atsuyuki Igarashi, Hidehisa Saeki, Hironobu Kaino, Takeshi Nagata
Topics & Concepts
MedicineOpen labelAtopic dermatitisJanus kinase inhibitorDermatologyDouble blindRandomized controlled trialSurgeryJanus kinaseInternal medicinePlaceboAlternative medicinePathologyCytokineDermatology and Skin DiseasesAllergic Rhinitis and SensitizationPsoriasis: Treatment and Pathogenesis